SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-086476
Filing Date
2024-07-25
Accepted
2024-07-25 16:00:08
Documents
13
Period of Report
2024-07-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cue-20240724.htm   iXBRL 8-K 62800
2 EX-99.1 cue-ex99_1.htm EX-99.1 26584
3 GRAPHIC img239719762_0.jpg GRAPHIC 27740
  Complete submission text file 0000950170-24-086476.txt   274325

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cue-20240724.xsd EX-101.SCH 44883
15 EXTRACTED XBRL INSTANCE DOCUMENT cue-20240724_htm.xml XML 4511
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 241141947
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)